Profil
Simon Mangcwatywa is currently the Chief Executive Officer at Sizwe Medical Fund since 2018.
Prior to this, he worked as the Medical Director at Adcock Ingram Holdings Ltd., Head-Scientific Operations at Novartis SA, and Head-Medical Affairs & Business Development at Litha Pharma (Pty) Ltd.
Aktiva positioner av Simon Mangcwatywa
| Företag | Position | Start |
|---|---|---|
Sizwe Medical Fund
Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Verkställande Direktör | 2018-01-01 |
Tidigare kända positioner av Simon Mangcwatywa
| Företag | Position | Slut |
|---|---|---|
Litha Pharma (Pty) Ltd.
Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices | Företagsledare/Principal | - |
Novartis SA
Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Företagsledare/Principal | - |
| ADCOCK INGRAM HOLDINGS LIMITED | Teknisk/Vetenskaplig/F&U Direktör | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Novartis SA
Novartis SA Pharmaceuticals: MajorHealth Technology Manufactures and markets health care, nutritional and agricultural products | Health Technology |
Adcock Ingram Holdings Ltd.
Adcock Ingram Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, markets and distributes non-price regulated health, personal and homecare products | Health Technology |
Litha Pharma (Pty) Ltd.
Litha Pharma (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets, and distributes pharmaceutical and generic products as well as medical devices | Health Technology |
Sizwe Medical Fund
Sizwe Medical Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
















